Personalized cancer vaccine shows promise, experts weigh in
Moderna developed the vaccine with Merck and tested it together with Keytruda, a common immunotherapy treatment for melanoma. If regulators approve the vaccine, thousands of patients who have had high-risk melanoma tumors removed could benefit from it as soon as next year, Moderna President Stephen Hoge said.
Top Videos

Personalized cancer vaccine shows promise, experts weigh in

Elissa Slotkin responds to Trump, DOJ threats of prosecution

Ex-girlfriend of De'Andre Booker testifies

Evidence technician testifies about De'Andre Booker's bathtub drain

Six rescued from Shelby Township fire

Early morning house fire kills 6-year-old boy in Detroit

Grand Theft Auto 6 has finally arrived

Trev Alberts expected to be University of Michigan's next athletic director: Students react

Investing in Michigan's Water Infrastructure

What is the 'Windows on Woodward' installation?

The wait is over: GTA 6 arrives at midnight

An awkward love triangle turns violent in Eastpointe

Ashley Elkins case: K9 handler testifies about dog’s findings

Pedestrian killed in crash on Gratiot

Lions coach Dan Campbell talks Aidan Hutchinson, Tampa

Attorney General Dana Nessel discusses nationwide outages

Protecting your money during tech outages

University of Michigan signs contract with Flock

New testimony in Ashley Elkins murder trial

Flint police, fire brawl during charity flag football game

Growing outage numbers frightening consumers

FAA router rollout paused ahead of holiday travel

MSP releases video of them finding missing hunter

Ashley Elkins case: Sister Aniya Elkins' testimony

Osama Siblani on Mike Rogers defamation lawsuit: ‘This is for the truth’
